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INTRODUCTION
One of the most relevant targets of neuroenhancement strategies is the N-methyl-D-aspartate receptor (NMDAR), which is the predominant site for inducing learning-related synaptic plasticity in the hippocampus (Lee and Silva, 2009 ). D-cycloserine (DCS), a partial agonist of the NMDAR that binds to the glycine-site and enhances receptor activation in the presence of glutamate (Norberg et al. 2008) , has recently been recognized for its potential in facilitating different cognitive processes.
Studies in rodents indicate that DCS, administered systemically or intracerebrally, improves numerous learning and memory processes in several paradigms (for reviews see Portero-Tresserra et al., 2013b; Villarejo-Rodríguez et al., 2010) . Furthermore, DCS attenuates mnemonic deficits in aged (Aura and Riekkinen, 2000) and stressed rats (Yamamoto et al., 2008) , and also in brain damaged rodents (Villarejo-Rodríguez et al., 2013; Yaka et al., 2007) . Evidence from studies in humans suggests that DCS promotes both the consolidation and extinction of conditioned fear (Kalisch et al., 2009 ) and may also enhance declarative learning (Onur et al., 2010) . Furthermore, it has also been shown that DCS improved cognition in Alzheimer's disease patients (Tsai et al., 1999) .
Moreover, it has been shown that DCS antagonized memory decreases produced by the muscarinic acetylcholine (ACh) receptor antagonist scopolamine (SCOP), which may be considered a pharmacological model for cholinergic cognitive impairment (Klinkenberg and Blokland, 2010) . Thus, the acute systemic pre-learning DCS infusion attenuated SCOP-induced deficits in acquisition of spatial tasks (Pitkänen et al., 1995) and brightness discrimination (Andersen et al., 2002) . As for intracerebral administration, early studies showed that the hippocampus may be a relevant area since DCS microinfusions into its dorsal portion ameliorated SCOP-induced spatial working memory impairment ( Kishi et al., 1998; Ohno and Watanabe, 1996) . Nevertheless, the physiological mechanisms by which such effects may occur have been poorly investigated. Several data suggest that DCS may improve SCOP-disrupted memory by acting on synaptic plasticity, and particularly longterm potentiation (LTP). On the one hand, SCOP administration impaired LTP in the CA1 hippocampal field (Calabresi et al., 1999; Sánchez et al., 2009) and altered hippocampal glutamate receptor levels (Falsafi et al., 2012) . On the other hand, DCS may enhance memory by facilitating NMDAR-dependent synaptic potentials and CA1 synaptic plasticity (Rouaud and Billard, 2003; Billard and Rouaud, 2007) . Accordingly, DCS reinstated LTP in CA1 and improved memory and neurological impairments in both brain-damaged (Yaka et al., 2007) and neural cell adhesion molecule-deficient mice (Kochlamazashvili et al., 2012) .
In this context, the aim of the present study was to assess whether intra-hippocampal DCS may prevent deficits elicited by muscarinic blockade, both at a behavioral and physiological level.
Thus, in the first experiment, we sought to confirm whether an acute DCS pre-learning treatment, as has been reported with intra-prelimbic cortex (PLC) administration (Portero-Treserra et al., 2013b) , reverses SCOP-induced deficits in social transmission of food preference (STFP), which is a paradigm of social learning involving an ethologically meaningful test of olfactory memory that is considered a relational memory test with no explicit spatial components (Eichenbaum, 2000) . STFP requires the integrity of the cholinergic system (Vale-Martinez et al., 2002) specifically in the ventral hippocampus (vHPC) (Carballo-Marquez et al., 2007) , where a substantial increase in ACh release has been demonstrated after learning (Gold et al., 2011) . The relevance of the vHPC has also been demonstrated in studies showing enhanced c-fos activity (Ross and Eichenbaum, 2006) and CREB phosphorylation (Countryman et al., 2005) in STFP learning. In the second experiment, we explored whether DCS may rescue putative deficits induced by SCOP in the induction/maintenance of LTP. To that end, electrophysiological recordings in CA1 synapses were carried out under the influence of DCS and SCOP perfusions (alone and in combination) in hippocampal slices both before and after a high frequency stimulation (HFS) protocol.
EXPERIMENTAL PROCEDURES

Experiment 1
Subjects
Fifty male Wistar rats, obtained from our laboratory breeding stock (Prolabor, Charles River Laboratories, Arbresle, France), with a mean age of 94.53 days (SD=6.231) and a mean weight of 402.795 g (SD=33.86) at the beginning of the experiment, were used as observer subjects. An 5 additional set of 36 male Wistar rats (mean age=57.25 d, SD=4.89; mean weight 225.17 g, SD=47.55) served as demonstrator subjects. Juvenile demonstrator rats were used in order to avoid fighting and favor social interaction (Vale-Martinez et al., 2002) . Procedures for housing, food restriction and habituation are explained in detail elsewhere (Portero-Tresserra et al., 2013a) . All procedures were carried out in compliance with the European Community Council Directive for care and use of laboratory animals (86/609/ECC) and with the Generalitat de Catalunya authorization (DOGC 2450 7/8/1997 .
Surgery
Observer rats were anesthetized with isoflurane and underwent stereotaxic implantation of bilateral chronic guide cannulae in the vHPC: AP, -5.0mm; ML, ±5.0 mm; and DV, -6.8 mm (Paxinos and Watson, 1997) , following procedures explained in detail elsewhere (Carballo-Marquez et al., 2009 ). After surgery, rats were returned to their home cages for 10 days (four for recovery, four for food restriction and two for rehabituation to ground food) before behavioral training.
Microinfusion procedure
The rats received 10µg/hemisphere of DCS (Sigma-Aldrich, Madrid, Spain) or phosphatebuffered saline (PBS; 0.1M, pH 7.4) infusions 20 min before STFP acquisition and 40µg/hemisphere SCOP (Scopolamine Hydrobromide USP, Sigma-Aldrich, Madrid, Spain) or PBS immediately after the social learning session. The solutions were infused bilaterally in a volume of 0.5 µl / hemisphere for 2 min (plus 1 min to allow for diffusion) following procedures described previously (Portero-Tresserra, et al., 2013a) . The dose of DCS selected has been established previously to facilitate olfactory learning tasks when injected into the PLC or the basolateral amygdala (Portero-Tresserra et al., 2013a,b; Villarejo-Rodríguez et al., 2010) , and other learning tasks, such as extinction of fear conditioning and appetitive learning, when injected into the basolateral amygdala or the infralimbic cortex (Peters & de Vries 2013; Walker et al. 2002) . The SCOP dose was chosen on the basis of a pilot study showing that intra vHPC injections of 40µg of SCOP disrupted STFP memory consolidation without inducing motor alterations (unpublished data).
Behavioral procedure
Habituation to food jars 6 The apparatus for STFP habituation, acquisition and testing is described in more detail in Portero-Tresserra et al. (2013b) . After seven days of food restriction and prior to surgery, observers and demonstrators were habituated for three days to powdered chow (Scientific Animal Food and Engineering, Augy, France). A similar procedure was repeated 7 d after surgery for the observers (two 45-min rehabituation sessions). Subsequently, animals were again food-restricted for two days before the training-testing sessions began.
STFP acquisition and test
The STFP training followed procedures explained elsewhere (Portero-Tresserra et al., 2013a ).
Essentially, the task began when a demonstrator was allowed to eat food flavored with 2.2% cocoa (Oxfam Fairtrade, Gent, Belgium) or 1% cinnamon (Carmencita, Alicante, Spain) for 30 min.
Immediately after, observers and demonstrators interacted for 30 min. All observers were tested 24 h after acquisition (45-min test) on the basis of previous studies showing amnesic effects after such a time period in SCOP-treated rats (Carballo-Marquez et al., 2009) . A preference score (percentage of trained food) was calculated as follows: 100 x (weight of trained food eaten/weight of all food eaten).
The number of times each observer sniffed the muzzle, body or anogenital region of the demonstrator, fighting and grooming (social interaction), and the number of forepaws (jar climbs during STFP test) were recorded (JVC, Everio Model GZ-X900). To rule out olfactory alterations due to the DCS and SCOP infusions, an additional olfactory perception test (described in Portero-Tresserra et al., 2013a) was conducted.
Histology
Perfusions and brains' post fixation were performed as explained elsewhere (Carballo-Marquez et al., 2009) . Coronal 40-µm sections were cut on a cryostat (Shandom Cryotome FSE, Thermo Electron Corporation, Massachusetts, USA), mounted and processed for acetylcholinesterase histochemistry and examined essentially as described previously (Portero-Tresserra et al., 2013a) .
Data analysis
The main analysis of the variable percentage of trained food was performed by means of ANOVA (PASW v20) with the group factor as the independent variable (VEH, DCS, SCOP and 7 DCS+SCOP). Specific between-group comparisons were performed and the Bonferroni correction was used. In addition, a one-sample t test against a constant (50) was used for each group to determine whether the percentage of trained food eaten was different from the chance level (50%).
To evaluate whether all the animals had similar opportunities of learning (similar social interaction levels), we carried out an ANOVA considering group as the independent variable, and the dependent variables were sniffs of demonstrator's muzzle, body and anogenital region, fighting and grooming. Pearson correlation tests were used in order to examine the relationship between such variables and the percentage of trained food selected. Additional ANOVAs were also used to analyze total food eaten and jar climbs, which evaluated motivation to eat and explore, respectively. Mixed analyses of variance were carried out to analyze neophobia, with regular food (mean g of food eaten during the last rehabituation session prior to training) and new food (mean g of total food eaten, trained + untrained, during the test) as dependent variables.
Regarding the olfactory test, an ANOVA was applied considering group (VEH, DCS, SCOP and DCS+SCOP) as the independent variable, and latency in finding the buried cookie as the dependent variable.
Experiment 2 Subjects
Electrophysiological assays were carried out in 10-week old male Wistar rats (Prolabor, Charles River Laboratories, Arbresle, France) in accordance with the European Communities Council Directive (86/609/EEC) for the care and use of laboratory animals.
Electrophysiological recordings in hippocampal slices
Procedures of the electrophysiological experiments are precisely described in Miguéns et al. (2011) . Drugs (DCS and SCOP) were prepared as stock solutions in PBS, stored frozen in the dark, and diluted to final concentration immediately before use. After obtaining stable synaptic responses for at least 20 min (baseline period), the different pharmacological treatments (DCS 50µM, DCS 100µM, SCOP 100µ, DCS 50µM + SCOP 100µM and DCS 100µM + SCOP 100µM) were perfused for 40 min. After 20 min of drug perfusion, Schaffer collateral fibers were tetanized with three 100-Hz 8 pulses of 100 µs duration every 20 s (HFS) to induce saturated-LTP. Following LTP induction, recording was carried out for 60 min, 20 min with drug and 40 min with KRB solution alone.
Data analysis
Data are expressed as the mean±SEM. The mean values of the initial slope of the fEPSP correspond to the averages of 1min intervals. In all experiments potentiation was assessed by analyzing the mean slope of the fEPSP measured at different time points after HFS application. A value of p<0.05 was considered statistically significant.
To evaluate whether the administration of the different drugs produced changes in the basal synaptic transmission, one-way ANOVAs (PASW v20) were performed in order to compare the mean of the fEPSP slope for 20 min before HFS of each experimental group (DCS 50µM, DCS 100µM, SCOP 100 µM, DCS 50µM + SCOP 100µM and DCS 100µM + SCOP 100µM) against the mean of the fEPSP slope during the 20-min baseline of the VEH group. To evaluate the effects of the drugs on LTP, a mixed ANOVA was carried out, in which the between-subject factor was group (VEH, DCS 50µM, DCS 100µM, SCOP100µM, DCS 50µM + SCOP 100µM and DCS 100µM + SCOP 100µM) and the within-subject factor was time (the last 10 minutes of the recording). Finally, the percentage of potentiation in the final recording (percentage of potentiation during the last 10 min of recording in relation to 10 min of the basal line prior to HFS) was considered as the dependent variable and the group factor as the independent variable (which included 6 categories). Contrast analyses were performed by means of Fisher's LSD. Differences were considered significant when p<0.05.
RESULTS
Experiment 1 Histology
For the final sample we only considered rats with their cannula tips bilaterally located in the vHPC within the area delimited by CA3 and CA1, and the cannulae were located from -4.52 to -5.20 mm posterior to bregma (Figure 1) . Eight rats were excluded from behavioral data analyses since their cannulae were incorrectly implanted (n=5) or due to technical problems during the infusion (n=3).
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Thus, the final sample was made up of 42 subjects distributed into the following groups: VEH (n=10), DCS (n=10), SCOP (n=12) and DCS+SCOP (n=10).
Behavioral testing
As depicted in Figure 2 , statistically significant between-group differences in the percentage of trained food eaten were found [F [3, 41] =8.858, P=0.0001]. Contrast analyses showed statistically significant differences between SCOP and the remaining groups: VEH (P=0.006), DCS (P=0.002) and DCS+SCOP (P<0.0001). SCOP rats apparently exhibited no preference for the trained food since it was not significantly different from chance level (t [11] =-1.675, P=0.122) whereas the other groups performed significantly above chance level (t [9] 's > 3.41 and P's < 0.01). The analysis of the social interaction measures showed no statistically significant group effects in any of the variables (muzzle: F [3, 41] =1.880, P=0.149; body: F [3, 41] =1.522, P=0.224; anogenital: F [3, 41] =0.785, P=0.510; fighting: F [3, 41] =0.724, P=0.544 and grooming F [3, 41] =0.169, P=0.917). Nor were there any statistically significant correlations between such variables and the percentage of trained food.
No statistically significant between-group differences were observed in exploration of both food jars (jar climbs) (F [3, 41] =0.472, P=0.706) and in the total amount of food consumed during the test session (F [3, 41] =0.257, P=0.856). In the analysis of possible neophobic effects, mixed ANOVA showed a significant effect of food (F [1, 38] =4.611, P=0.038) but no significant effects of group (F [3, 38] =1.081, P=0.369) or group x food interaction (F [3, 38] =1.614, P=0.202). The performance in this task did not seem to be related to changes in olfactory sensitivity as no statistically significant between-group differences were observed when the latency to find a buried sweet-smelling cookie was analyzed 24h after injections (F [3, 41] = 0.139, P = 0.936).
Experiment 2
After a 20-min basal period and stable fEPSP responses, the different drugs [DCS 50µM (n=5), DCS 100µM (n=4), SCOP 100µM (n=8), DCS 50µM+SCOP 100µM (n=5), DCS 100µM+SCOP 100µM (n=4)] were added into the KRB in the corresponding groups. The application of DCS to hippocampal slices induced a slight potentiation of basal synaptic transmission in all the groups (see Figures 3 and 4) . The ANOVA comparing the fEPSP responses 20 min after drug perfusion (time before HFS) versus the 20-min of baseline period of the VEH group showed statistically significant differences in the following groups: DCS 50µM (F [1, 11] =8.862, P=0.014), DCS 100µM (F [1, 10] =13.824, P=0.005), DCS 50µM+SCOP 100µM (F [1, 13] =6.514, P=0.025) and DCS 100µM+SCOP 100µM (F [1, 12] =5.258, P=0.043), but not in the SCOP 100µM group (F [1, 14] =0.467, P=0.506) (Figure5A).
After HFS and following 20 min of drug perfusion, the effects of the drugs on LTP were analyzed (Figures 3 and 4) . The ANOVA of the last 10 minutes of recording showed that the group (F [5, 31] =3.919, P=0.007) and time (F [9, 279] =6.434, P<0.0001) factors were statistically significant, but not the interaction group x time [F [45, 279] =1.104, P=0.311]. Specifically, the group differences were found between the SCOP 100µM group and the remaining groups: VEH (P=0.024), DCS 50µM (P<0.0001), DCS 100µM (P=0.003), DCS 50µM+SCOP 100µM (P=0.05) and DCS 100µM+SCOP 100µM (P=0.033) (Figures 3 and 4) . Hence, the administration of DCS offset the deficit on the LTP maintenance induced by SCOP. Additionally, the analysis of the potentiation percentage in the final recording indicated statistically significant between-group differences [F [5, 31] =2.866, P=0.0306]. The differences were appreciated between the SCOP 100µM group vs. VEH (P=0.019), DCS 50µM+SCOP 100µM (P=0.05), DCS 100µM+SCOP 100µM (P=0.05), DCS 50µM (P=0.002) and DCS 100µM (P=0.023) ( Figure 5B ).
DISCUSSION
The present study provides behavioral and electrophysiological evidence that the potentiation of glutamatergic activity in the hippocampus, with microinfusion of the partial NMDAR agonist DCS, rescues relational memory deficits and in-vitro LTP maintenance impairment, both induced by the administration of the muscarinic antagonist SCOP. In the experiment 1, vHPC administration of DCS prior to social interaction prevented the SCOP-induced amnesia in the 24-h memory test, as the trained food preference of the DCS+SCOP group was significantly higher than the chance level and that of the SCOP group, but not thanVEH and DCS groups. These results cannot be attributed to alterations in olfactory perception, social investigation, neophobic responses or motor activity. The counteraction of SCOP-induced deficits is consistent with early reports suggesting that the hippocampus may be a critical region for the action of DCS in the reversion of SCOP-induced impairments in spatial working memory (Kishi et al., 1998; Ohno and Watanabe, 1996) . Previous research also showed that the systemic pre-learning injection of DCS attenuated SCOP-induced deficits both in spatial (Pitkänen et al., 1995) and non-spatial paradigms (Andersen et al., 2002) . Therefore, the present results provide more evidence as to a potential pervasive role of DCS in the reversion of memory deficits induced by different causes, such as cholinergic or glutamatergic dysfunction (Kawabe et al., 1998) , aging (Aura and Riekkinen, 2000) , stress (Yamamoto et al., 2008) , traumatic brain injury and hippocampal, medial septal or thalamic lesions (Villarejo-Rodríguez et al., 2013; Yaka et al., 2007) . Data from experiment 2 showed that the two doses of DCS enhanced the potentiation percentage in SCOP-treated slices at the end of registering, which would suggest that the cellular mechanism underlying the reversion of (Yaka et al., 2007) , NCAM-deficiency (Kochlamazashvili et al., 2012) , or aging (Billard and Rouaud, 2007) . It has been shown that DCS not only facilitated NMDAR activation and synaptic plasticity in young rats, but was significantly more potent in aged animals, thus reversing the age-related deficit of NMDAR-mediated LTP and long-term depression (LTD) (Billard and Rouaud, 2007) .
As to the behavioral effects of DCS in non-SCOP treated rats, the present study showed that DCS did not improve STFP memory, which is consistent with data from previous experiments showing that DCS in the PLC ameliorated SCOP-induced deficits in the STFP task, but did not enhance memory when injected in control rats (Portero-Tresserra et al., 2013a) . Such findings would suggest, as discussed previously (Portero-Tresserra et al., 2013a) , that DCS may enhance implicit or procedural tasks, but that its facilitative influence on relational paradigms seems to be more restricted.
Another factor that may be considered to explain the effects of DCS in control subjects is the targeted cognitive process, since some studies showed a beneficial effect of DCS specifically in the extinction of fear conditioning (Ren et al., 2013) . In contrast, in the present experiment DCS administration probably affected the original learning/early consolidation as the drug was injected prior to STFP training. Regarding the physiological effects of DCS, data from experiment 2 showed that DCS in non SCOP-treated slices did not enhance hippocampal LTP. This contrasts with an earlier study showing that DCS facilitated synaptic plasticity of glutamatergic transmission in the CA1 field, lowering the threshold to induce a lasting potentiation (Rouaud and Billard, 2003) . Methodological factors may explain divergence in findings since the Rouaud and Billard (2003) study used a protocol inducing a shorter potentiation. The present data also indicated that the administration of DCS in CA1, before HFS, increased the magnitude of the fEPSP recorded both in slices treated and untreated with SCOP.
Thus, all the DCS groups showed an increased percentage in the fEPSP slope from the 20-min baseline to the initial 20-min drug presence condition (7.78%, 11.85%, 6.38% and 7.78%). These findings may be interpreted as an enhancement in synaptic transmission (although it did not significantly endure after HFS), which would agree with the Rouaud and Billard (2003) work indicating that DCS facilitated NMDAR-mediated fEPSPs in the CA1 region of rat hippocampal slices. Such results found in the CA1 hippocampal region also confirm an early report demonstrating that DCS increased in vivo the excitability of dentate granule cells (Pitkänen et al., 1994) .
Nevertheless, the fact that DCS enhanced NMDAR-dependent synaptic potentials but not LTP or behavioral memory in non-SCOP groups was not wholly unexpected as earlier studies indicated that DCS had a more robust effect in animals showing a certain cognitive deficit (Aura and Riekkinen, 2000; Billard and Rouaud, 2007) .
The present results also confirm that the infusion of SCOP (40µg/hemisphere) in the vHPC immediately after the STFP acquisition produced a striking deficit in the 24h-memory test, detected by the poor performance of the SCOP group, which did not differ from the chance level and was significantly worse than that of the VEH group. Such data corroborate the contribution of muscarinic receptors in the consolidation of this social form of relational memory as STFP impairments had also been observed when a lower dose of SCOP (20µg) was administered in the vHPC or the PLC 13 (Carballo-Marquez et al., 2009; Portero-Tresserra et al., 2013a) . Interestingly, muscarinic receptors appear to contribute to the recognition of socially relevant odors but not neutral odors, since systemic administration of SCOP significantly disrupted urine estrous odor but no mint odor habituation (Miranda et al. 2009 ). The importance for STFP acquisition of the cholinergic transmission has also been demonstrated in a microdialysis study showing a significant increase (200%) of ACh release in the vHPC after exposure to a rat that had eaten the novel food, which was not found in the PLC (Gold et al., 2011) . Such effects are consistent with the involvement of the cholinergic system in regulating the salience of odors during active sensing of the olfactory environment (Rothermel et al., 2014) , which agrees with the proposed role of ACh in attentional mechanisms. The current electrophysiological data also demonstrated that the SCOP (100 µM) perfusion in hippocampal slices significantly suppressed the LTP maintenance in CA1 synapses, as indicated by the lower percentage of potentiation in the last 10 min of recording by the SCOP group vs. the remaining groups, thus confirming previous findings (Sánchez et al., 2009) . Moreover, detrimental effects of SCOP on LTP have also been found in CA1 synapses in vivo (Ovsepian et al., 2004) and in corticostriatal synapses (Calabresi et al., 1999) . In agreement with the above, it has been reported that muscarinic receptor activation facilitates the induction of LTP in rat hippocampal slices (Buchanan et al., 2010) , which would corroborate that such receptors are a crucial event in this form of synaptic plasticity.
Taken together, the results from both experiments point to an interactive relationship between glutamatergic and cholinergic transmission in memory modulation, previously suggested by behavioral pharmacological studies (Ohno and Watanabe, 1996) . For instance, concomitant administration of sub-threshold doses of SCOP and NMDA antagonists induced amnesia in inhibitory avoidance and spatial learning (Khakpai et al., 2012) and sub-effective doses of NMDA and physostigmine exerted memory-enhancing properties (Jafari-Sabet, 2006) . There is also evidence at the cellular level indicating the interaction between cholinergic and glutamatergic systems in mediating memory processes on the grounds of their involvement in synaptic plasticity. Markram and Segal (1990) demonstrated that the administration of ACh increases the probability of generating hippocampal NMDA-dependent LTP. Furthermore, the activation of muscarinic receptors can also lead to LTD of NMDAR-mediated synaptic transmission (Jo et al., 2010) . In this sense, it has been shown that M1 muscarinic receptors induce the opening of NMDA receptors through the inhibition of SK channels (Buchanan et al., 2010) . Moreover, cooperation between cholinergic and glutamatergic receptors would seem to be essential to induce BDNF-dependent long-lasting memory storage (Navakkode and Korte, 2012) . Additionally, other mechanisms by which SCOP may disrupt LTP have been suggested, such as down-regulation of protein kinase C and nitric oxide (Saraf et al., 2010) , which are required for LTP induction and maintenance (Knafo et al., 2012) . Therefore, it is widely known that muscarinic ACh receptors and NMDAR are important for learning and memory, although the specific manner in which they interact is less understood (Doguc et al., 2012) . Indeed, few studies had assessed the brain regions where such an interaction may take place (Khakpai et al., 2012) or the function of intracerebral DCS as a preventive treatment for mnemonic deficits produced by cholinergic deficiency (Portero-Tresserra et al., 2013a) , which enhances the significance of the current research.
In summary, in the present study we found a correspondence between behavioral and cellular findings. In both experiments, the administration of DCS was able to rescue SCOP-induced impairments since the DCS+SCOP groups showed comparable results in STFP memory and electrophysiological recording. Consequently, DCS effects on STFP memory may be interpreted in terms of enhancing hippocampal LTP, which may be considered as a crucial element in memory or other forms of experience-dependent plasticity. Although there is no general consensus regarding LTP as a model for the synaptic changes that contribute to the neural circuit modifications underlying all types of experience-dependent plasticity, accumulating evidence would suggest that this mechanism has important functional roles in many brain areas and in different circumstances (Malenka, 2003) .
Our results, therefore, provide functional evidence that DCS may be helpful in reducing memory impairments associated with cholinergic depletion, probably by enhancing LTP. Hence, our findings support the use of NMDA-glycine site agonists, such as DCS, as potential treatments for the alleviation of memory alteration occurring in neurodegenerative or neurological diseases. 
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